Nancy Richert

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand

Bibiana Bielekova, Bonnie L. Goodwin, Nancy Richert et al. · Nature Medicine · 2000 · 819 citations

Neurodegenerative Diseases, Encephalitogenic Potential, Neurobiology Of Disease +14

Human Multidrug-Resistant Cell Lines: Increased <i>mdr</i> 1 Expression Can Precede Gene Amplification

Donglai Shen, Antonio Tito Fojo, Janice E. Chin et al. · Science · 1986 · 604 citations

Engineering, Mdr1 Mrna, Cancer Biology +17

Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins.

Donglai Shen, Carol Cardarelli, Jinyoung Hwang et al. · Journal of Biological Chemistry · 1986 · 466 citations · Full text

Pathology, Cancer Biology, Tumor Biology +17

Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis

Anthony Traboulsee, Jack H. Simon, L. Stone et al. · American Journal of Neuroradiology · 2015 · 327 citations · Full text

Neurological Disorder, Diagnosis, Clinical Guidelines +18

Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β

Bibiana Bielekova, Nancy Richert, T. Howard et al. · Proceedings of the National Academy of Sciences · 2004 · 313 citations · Full text

Neurological Disorder, Immunology, Immune System +17